Exciting news about the 2016 Impact Factor and JOPM performance

    loading  Checking for direct PDF access through Ovid

Excerpt

The 2016 Thomson Reuters impact factors (IF) have recently been released. While the IF is only one metric used to assess the quality of a journal, many authors rely on it when deciding where to send their papers. A journal with an IF of 2.000 or greater is often regarded by researchers as being much more prestigious and of higher scientific quality than one less than 2.000. I am, therefore, delighted to announce on behalf of the whole editorial team our journal's impact factor for 2016 is 2.043. This represents a 9.9% rise from the 2015 result (1.859) and is testament to the many quality papers that are being submitted and published in JOPM, and subsequently cited in the scientific literature in the ensuing 2 years.
As a result of the increased IF, we have climbed in the ranking of pathology journals from 41/79 in 2015 to 35/79 in 2016. As a specialty journal, we should be very proud of this achievement as there are many general pathology journals now ranked lower than JOPM. Our ranking in the dentistry, oral surgery, and medicine category has not changed significantly from 2015 and is currently 26/90 (it was 25/91 in 2015). It is hoped that we can climb up the rankings further in future years.
The relative proportion of accept decisions has also risen from 24.5% of the total submissions in 2015 to 32.4% in 2016. The review process is still as rigorous as expected, so it therefore, seems likely that higher quality research papers are being submitted to the journal. As an editor it is a great privilege to read cutting edge research papers and learn from review articles before they are published. We now have an early view facility and papers are cited on PubMed rapidly after acceptance, while waiting listing in a journal issue.
    loading  Loading Related Articles